Realizing the Promise of Artificial Intelligence in Pathology

Digital pathology specialist Proscia has been working hard to change the current pathology narrative. The Philadelphia, PA-based company has made several moves to accomplish this goal and its most recent move is a collaboration with the University of California, San Francisco (UCSF). Proscia builds software and has a platform for imaging workflow management that allows a pathologist in the lab to take digitized images of the glass slides the tissue biopsy sites on and move these images through workflows. The company uses its computational AI-based applications to find patterns in the imaging and transform that information into something meaningful for the pathologist. However, Proscia doesn’t have a laboratory and that’s where UCSF comes in, said Nathan Buchbinder, the firm’s co-founder and Chief Product Officer. He noted the collaboration with UCSF is essential to Proscia’s growth as it builds on the company’s software’s deep learning capabilities. "Building AI takes a lot of data and a lot of focus and research on how changes in that data – how changes in different laboratories impact the performance of artificial intelligence,” Buchbinder told MD+DI. “So, working with a group like UCSF allows us to not just collect the data but also the variety of information that we need to ensure the AI we build works in practic...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Business Source Type: news